Skip to content
Tuesday, November 17, 2026
Goldspot Pens

The Zimbabwean Government Turns Down ‘Lopsided’ US Healthcare Assistance Agreement Over Data Apprehensions

Medical aid illustration
The offered American funding was intended for initiatives for treating and preventing HIV/Aids, TB, and malaria.

Zimbabwe has turned down a significant US healthcare agreement valued at $367m (£272m) spanning five years over Washington's request for sensitive information.

This rejection became public following a official document dated December was leaked, which showed Head of State Emmerson Mnangagwa deemed the deal was "lopsided".

An official spokesman later clarified that the United States was seeking genetic material for scientific study and profit while was unwilling to share the benefits from any future treatments.

"We are forced to start the difficult and regrettable process of winding down our support in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.

Her embassy noted the United States had furnished over $1.9bn for health programmes to Zimbabwe during the past twenty years.

A medical body in Zimbabwe has appealed for more negotiations to secure a agreement suitable to all parties so the nation's vital HIV programme can proceed.

Wider Implications

This development comes after a comparable case in neighbouring Kenya, where a high court suspended a similar health funding agreement following legal challenges were raised about the safety of Kenyans' health data.

After resuming office recently, US President Donald Trump has drastically cut overseas assistance and shut down the key foreign aid agency.

USAID had overseen assistance for the US government, but Trump stated its expenditure was "inefficient" and his administration was pursuing direct bilateral deals to boost transparency and accountability.

Based on reports, 16 African countries have to date signed similar agreements, representing over $18.3bn of fresh investment.

Details of the Rejected Agreement

The money for Zimbabwe would have supported "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.

"We are confident this partnership could have provided extraordinary benefits for the people of Zimbabwe, especially the 1.2 million presently receiving antiretroviral therapy through US-supported programmes," Tremont said.

However, official spokesman Nick Mangwana maintained the arrangement was "unequal".

"The proposal required Zimbabwe to share its genetic material and health information over an extended period, without any equivalent promise of benefiting from any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that could result from that provided information," Mangwana explained.

"Put simply, our nation would provide the basic resources for medical research with no assurance that the end products would be accessible to our population if a future disease outbreak arise."

Sovereignty and International Frameworks

He also pointed out that the American exit from the global health body and its pursuit of one-on-one health agreements were upending systems previously set up through the global organization.

The spokesperson cited its Pathogen Access and Benefit Sharing system designed to deal with potential global health emergencies.

"This system is intended to guarantee that when a country provides its information, the resulting advantages – such as vaccines and treatments – are shared equitably, not commercialised exclusively by those with the capability to develop them."

Zimbabwe's reservations regarding the US deal "must not be interpreted as hostility towards the US," he added.

"We encourage continued dialogue with our American counterparts on how subsequent co-operation could be designed in a way that respects the independence and dignity of each country."

Health Experts Reaction

A leading public health body said it understood the government's concerns, but suggested that negotiations should continue considering much of the country's HIV programmes were funded by external financing.

"If specific concerns arise, including those involving data governance or agreement terms, these can often be addressed via detailed discussion and mutually agreed protections," it added.

The halted deal emphasises the continuing tensions between receiving crucial international aid and safeguarding a country's data in an increasingly interconnected world.

By

Zachary Marshall

Liam Visser is a Dutch journalist and pen enthusiast with over a decade of experience in fine writing instruments.

Goldspot Pens

Type to search articles.